Mechanism of Action of for Treatment of Idiopathic Membranous Nephropathy Based on Network Pharmacology

Overview

Journal Ren Fail

Publisher Informa Healthcare

Date 2022 Feb 17

PMID 35172688

Authors

Honghong Shi

Yanjuan Hou

Xiaole Su

Jun Qiao

Qian Wang

Xiaojiao Guo

Zhihong Gao

Lihua Wang

Affiliations

Soon will be listed here.

Abstract

Background: Although thunder god vine () has been widely used for treatment of idiopathic membranous nephropathy (IMN), the pharmacological mechanisms underlying its effects are still unclear. This study investigated potential therapeutic targets and the pharmacological mechanism of for the treatment of IMN based on network pharmacology.

Methods: Active components of were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. IMN-associated target genes were collected from the GeneCards, DisGeNET, and OMIM databases. VENNY 2.1 was used to identify the overlapping genes between active compounds of and IMN target genes. The STRING database and Cytoscape 3.7.2 software were used to analyze interactions among overlapping genes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses of the targets were performed using Rx64 4.0.2 software, colorspace, stringi, DOSE, clusterProfiler, and enrichplot packages.

Results: A total of 153 compound-related genes and 1485 IMN-related genes were obtained, and 45 core genes that overlapped between both categories were identified. The protein-protein interaction network and MCODE results indicated that the targets TP53, MAPK8, MAPK14, STAT3, IFNG, ICAM1, IL4, TGFB1, PPARG, and MMP1 play important roles in the treatment of on IMN. Enrichment analysis showed that the main pathways of targets were the AGE signaling pathway, IL-17 signaling pathway, TNF signaling pathway, and Toll-like receptor signaling pathway.

Conclusion: This study revealed potential multi-component and multi-target mechanisms of for the treatment of IMN based on network pharmacological, and provided a scientific basis for further experimental studies.

Citing Articles

Huang M, Liu J, Li X Open Life Sci. 2024; 19(1):20220921.

PMID: 39071497 PMC: 11282913. DOI: 10.1515/biol-2022-0921.

Effectiveness and safety of tripterygium wilfordii poly-glycosides on glomerulonephritis: a systematic review and meta-analysis.

Yan X, Shi J, Zhang Y, Liu J, Lin X, Yu C Front Pharmacol. 2024; 15:1339153.

PMID: 38841368 PMC: 11150713. DOI: 10.3389/fphar.2024.1339153.

QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.

Gao F, Zhou Y, Yu B, Xie H, Shi Y, Zhang X Heliyon. 2024; 10(1):e23535.

PMID: 38223704 PMC: 10784173. DOI: 10.1016/j.heliyon.2023.e23535.

Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.

Miao H, Zhang Y, Yu X, Zou L, Zhao Y Front Pharmacol. 2022; 13:969930.

PMID: 36176440 PMC: 9513429. DOI: 10.3389/fphar.2022.969930.

References

Polanco N, Gutierrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D . Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment. Nephrol Dial Transplant. 2011; 27(1):231-4. DOI: 10.1093/ndt/gfr285. View

Meng S, Sun L, Wang L, Lin Z, Liu Z, Xi L . Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity. Colloids Surf B Biointerfaces. 2019; 182:110352. DOI: 10.1016/j.colsurfb.2019.110352. View

Malik S, Bhatia J, Suchal K, Gamad N, Dinda A, Gupta Y . Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Exp Toxicol Pathol. 2015; 67(7-8):427-33. DOI: 10.1016/j.etp.2015.04.008. View

Huang Y, Fu S, Lu K, Chen J, Hsieh H, Sytwu H . Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathy. Oncotarget. 2018; 8(67):111631-111641. PMC: 5762348. DOI: 10.18632/oncotarget.22881. View

Sharma D, Gondaliya P, Tiwari V, Kalia K . Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signalling. Biomed Pharmacother. 2018; 109:1610-1619. DOI: 10.1016/j.biopha.2018.10.195. View

Jin L, Pan M, Ye H, Zheng Y, Chen Y, Huang W . Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway. Exp Physiol. 2018; 104(2):220-230. DOI: 10.1113/EP087190. View

Zhou Y, Hong Y, Huang H . Triptolide Attenuates Inflammatory Response in Membranous Glomerulo-Nephritis Rat via Downregulation of NF-κB Signaling Pathway. Kidney Blood Press Res. 2016; 41(6):901-910. DOI: 10.1159/000452591. View

Ji W, Chen Y, Zhao X, Guo Y, Zhong L, Li H . Beneficial effects of tripterygium glycosides tablet on biomarkers in patients with ankylosing spondylitis. Mol Med Rep. 2015; 12(1):684-90. DOI: 10.3892/mmr.2015.3448. View

Neale T, Ruger B, MacAulay H, Dunbar P, Hasan Q, Bourke A . Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol. 1995; 146(6):1444-54. PMC: 1870891. View

10.

Bogoyevitch M, Boehm I, Oakley A, Ketterman A, Barr R . Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta. 2004; 1697(1-2):89-101. DOI: 10.1016/j.bbapap.2003.11.016. View

11.

Ma Z, Zhang X, Li L, Yang W, Wang S, Guo X . Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats. J Diabetes Res. 2015; 2015:390428. PMC: 4549548. DOI: 10.1155/2015/390428. View

12.

Sha W, Shen L, Zhou L, Xu D, Yang J, Lu G . Silencing of CXCL12 performs a protective effect on C5b-9-induced injury in podocytes. Int Urol Nephrol. 2018; 50(8):1535-1544. DOI: 10.1007/s11255-018-1799-8. View

13.

Shang S, Cai G, Duan S, Li P, Li Q, Chen X . Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy. BMC Nephrol. 2018; 19(1):182. PMC: 6052665. DOI: 10.1186/s12882-018-0967-5. View

14.

Zhang C, Leng L, Li Z, Zhao Y, Jiao J . Identification of biomarkers and drug repurposing candidates based on an immune-, inflammation- and membranous glomerulonephritis-associated triplets network for membranous glomerulonephritis. BMC Med Genomics. 2020; 13(1):5. PMC: 6947948. DOI: 10.1186/s12920-019-0655-8. View

15.

Ru J, Li P, Wang J, Zhou W, Li B, Huang C . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6:13. PMC: 4001360. DOI: 10.1186/1758-2946-6-13. View

16.

Leeuwis J, Nguyen T, Dendooven A, Kok R, Goldschmeding R . Targeting podocyte-associated diseases. Adv Drug Deliv Rev. 2010; 62(14):1325-36. DOI: 10.1016/j.addr.2010.08.012. View

17.

Furst D, Tseng C, Clements P, Strange C, Tashkin D, Roth M . Adverse events during the Scleroderma Lung Study. Am J Med. 2011; 124(5):459-67. DOI: 10.1016/j.amjmed.2010.12.009. View

18.

Sha W, Shen L, Zhou L, Xu D, Lu G . Down-regulation of miR-186 contributes to podocytes apoptosis in membranous nephropathy. Biomed Pharmacother. 2015; 75:179-84. DOI: 10.1016/j.biopha.2015.07.021. View

19.

Masutani K, Taniguchi M, Nakashima H, Yotsueda H, Kudoh Y, Tsuruya K . Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy. Nephrol Dial Transplant. 2004; 19(3):580-6. DOI: 10.1093/ndt/gfg572. View

20.

Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y . A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012; 13(6):6964-6982. PMC: 3397506. DOI: 10.3390/ijms13066964. View